Skip to content

Clinical trials

Observational Retinitis Pigmentosa trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Phase: Observational Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20053
20061
20072
20101
20111
20121
20132
20142
20151
20161
20173
20193
20202
20214
20221
20233
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting11
Active, not recruiting4
Terminated4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)8
Jaeb Center for Health Research3
Johns Hopkins University3
Columbia University2
Nanoscope Therapeutics Inc.2
National Center for Research Resources (NCRR)2
Ray Therapeutics, Inc.2
Food and Drug Administration (FDA)1
Foundation Fighting Blindness1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa38
Retinal Degeneration8
Usher Syndromes7
Macular Degeneration5
Retinal Dystrophies5
Stargardt Disease5
Eye Diseases, Hereditary4
Leber Congenital Amaurosis4
Retinal Diseases4
Choroideremia3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.